Aspen Pharmacare (OTCMKTS:APNHY) Shares Gap Down - What's Next?

Key Points

• Aspen Pharmacare's stock price gapped down from $6.08 to $5.75 prior to trading, marking a 5.3% decline.
• The company has moving averages of $6.29 (50-day) and $7.15 (200-day), indicating a potential short-term weakness in its stock performance.
• Aspen Pharmacare specializes in specialty and branded pharmaceutical products, including anesthetics and anticoagulants, operating globally through its various segments.

Aspen Pharmacare (OTCMKTS:APNHY - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $6.08, but opened at $5.75. Aspen Pharmacare shares last traded at $5.75, with a volume of 500 shares.

Aspen Pharmacare Stock Performance

The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.25 and a current ratio of 2.21. The stock has a 50 day moving average price of $6.21 and a two-hundred day moving average price of $7.08.

Aspen Pharmacare Company Profile

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.